Philippe Gevaert
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Philippe Gevaert from the Ghent University is known for his research on nasal polyposis, particularly in relation to allergies and asthma. His work has explored the underlying mechanisms of nasal polyps, which are often associated with chronic rhinosinusitis and allergic conditions.
He has contributed to understanding the inflammatory processes involved in nasal polyposis, as well as potential treatments and management strategies.
He was the first to study biological treatments such as anti-il-5 and anti-IgE in chronic rhinosinusitis with nasal polyps.
References
Highly Cited Researcher 2024 (UGent, 2024): Prof. dr. Philippe Gevaert | Ghent University
Persistent rhinitis:
Une étude dénonce l'utilisation excessive du spray nasal en vente libre
Anti-Il-5 treatment: [1]
Medical doctor (UGent, 1998): Prof. dr. Philippe Gevaert | UZ Gent
.svg){kind=small}   | This biographical article about a Belgian academic is a stub. You can help Wikipedia by adding missing information. |
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.